Exciting R2B funding news
iCAN had a strong showing in Business Finland’s last Research to Business funding round. Four out of eight projects funded…
iCAN data analyst position open at HUS and bioinformatician at FIMM
HUS IT Management is looking for a data analyst acting as an expert of HUS datasets at iCAN for a…
New subprojects initiating in the iCAN Flagship Project
The iCAN Flagship Project has taken tremendous steps in 2022 with establishment of the pipeline for prospective sample collection and…
iCAN science seminar series, spring 2023
We are happy to announce that the iCAN science seminar series continues in the spring term 2023. The seminar series…
Patients and researchers met at the Lung Cancer Awareness Month event
Patients and researchers met at the Lung Cancer Awareness Month eventIn November, it is International Lung Cancer Awareness Month. At…
Patients as partners in research – a debate on inclusion at the Mission: Possible symposium
iCAN, the flagship of digital personalised cancer medicine, and the Finnish Cancer Institute Foundation organised the symposium Mission: Possible –…
Research in the spotlight – Lung Cancer Month patient-researcher meeting
November is International Lung Cancer Awareness Month. During the month, Finnish Cancer Patients will highlight the experiences of lung cancer…
iCAN science seminar series, Fall 2022
Welcome to our new, exciting iCAN science seminar series! The seminar series is for all researchers and students interested in…
Satu Mustjoki new iCAN Scientific Director
iCAN Steering Board supported today the nomination of Satu Mustjoki as iCAN’s new Scientific Director. The Steering Board also expressed its…
iCAN Webinar Recordings: Implementing transparent and high-quality real-world data networks for evidence generation at scale
The webinar held on May 11, 2022 focused on how to implement high-quality, harmonized RWD/RWE networks for cancer research, decision…
End of content
End of content